Castle Biosciences stock falls following Medicare coverage denial
Investing.com -- Shares of Castle Biosciences (NASDAQ: CSTL ) tumbled 9% after Novitas, a regional Medicare contractor, finalized its decision not to cover one of the company's cancer ...
Pfizer must face lawsuit over diversity fellowship program, US court rules
By Nate Raymond (NS: RYMD ) (Reuters) -A U.S. appeals court on Friday revived a lawsuit by a conservative group opposed to diversity initiatives in medicine t...
US insurers slump as Los Angeles wildfire loss estimates hit $20 billion
By Manya Saini (Reuters) - U.S. insurance stocks slid on Friday as analysts estimated insured losses from the wildfires menacing Los Angeles could reach as high as $20 billion, potentially ...
